FOLH1 and neoplasm: Furthermore, a recently published clinical study of 16 patients using both orally ingested and topical MSG demonstrated that while SG uptake of 68Ga-PSMA-11 can be reduced with this intervention, tumor uptake of 68Ga-PSMA-11 also declined which makes this approach unlikely to be clinically useful in the setting of TRT [30].